Written by some of the world’s leading authorities on haemoglobin disorders, this second revised edition of Guidelines for the Clinical Management of Thalassaemia provides medical professionals with a clear, comprehensive guide to the optimal treatment of thalassaemia, based on scientific evidence, clinical studies and observations. The information provided here has been meticulously compiled by experts fully aware of the many different circumstances in which medical personnel strive to treat patients with thalassaemia. As such, it sets out to provide a full guide to the treatment to which every patient everywhere is entitled, including access to sufficient quantities of safe blood and iron chelation therapy, as well as offering a comprehensive assessment of groundbreaking advances in chelation therapy, other treatment options and the long-awaited final cure, including stem cell transplantation and gene therapy.
Guidelines for the Clinical Management of Thalassaemia [Internet] / M. Cappellini, A. Cohen, A. Eleftheriou, A. Piga, J. Porter, A. Taher - In: Guidelines for the Clinical Management of Thalassaemia [Internet]. 2nd Revised edition / [a cura di] MD. Cappellini, A. Cohen,A. Eleftheriou, A. Piga, J. Porter, A. Taher. - 2nd Revised edition.. - Nicosia (CYPRUS): 2008. : Thalassaemia International Federation TIF ; 2008., 2014. - ISBN 978-9963-623-70-9.
Guidelines for the Clinical Management of Thalassaemia [Internet]
M. Cappellini;
2014
Abstract
Written by some of the world’s leading authorities on haemoglobin disorders, this second revised edition of Guidelines for the Clinical Management of Thalassaemia provides medical professionals with a clear, comprehensive guide to the optimal treatment of thalassaemia, based on scientific evidence, clinical studies and observations. The information provided here has been meticulously compiled by experts fully aware of the many different circumstances in which medical personnel strive to treat patients with thalassaemia. As such, it sets out to provide a full guide to the treatment to which every patient everywhere is entitled, including access to sufficient quantities of safe blood and iron chelation therapy, as well as offering a comprehensive assessment of groundbreaking advances in chelation therapy, other treatment options and the long-awaited final cure, including stem cell transplantation and gene therapy.File | Dimensione | Formato | |
---|---|---|---|
guidelines.pdf
accesso aperto
Tipologia:
Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione
3.44 MB
Formato
Adobe PDF
|
3.44 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.